Lumida
/CYH
⌘K
Community Health Systems Inc

Community Health Systems Inc

CYH
$3.30USD↓-2.37%-0.08 today

MARKET CAP

465.0M

P/E (TTM)

4.5x

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2
$4

AI Summary

Stalk
TrimMedium

In a Stage 4 decline with confirmed lower highs and lower lows, CYH’s medium-term bias is bearish absent mean-reversion eligibility. The recent bounce into a cluster of falling EMAs and overhead 50/200 DMAs appears corrective. Execution should be deferred until price meets and rejects the dynamic resistance zone. A failure to reclaim that area will offer a sell entry, while a sustained break above would invalidate the bearish posture.

  • ↑$85M invested in ambulatory surgery centers to capture rising outpatient demand.
  • ↑Same-store net revenue +3.1% YoY, signaling initial volume recovery.
  • ↓Adjusted EBITDA declined 17.8% YoY, undershooting internal targets.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Community Health Systems, Inc. (NYSE: CYH) is a leading operator of general acute care hospitals with a focus on delivering high-quality healthcare services primarily in non-urban markets across the United States. The company emphasizes expanding outpatient capabilities and enhancing patient care through strategic acquisitions, particularly ambulatory surgery centers. Given its extensive network, CHS plays a critical role in providing accessible healthcare, but it currently faces numerous operational challenges amid a changing healthcare landscape.

Bull says

  • ↑$85M invested in ambulatory surgery centers to capture rising outpatient demand.
  • ↑Same-store net revenue +3.1% YoY, signaling initial volume recovery.
  • ↑Leverage ratio improved to 6.5× via asset divestitures, boosting liquidity.
  • ↑Analysts raised earnings estimates, reflecting growing optimism on recovery.
  • ↑Payer mix trends set to improve margins in back half.
  • ↑High earnings yield and solid profitability factors point to undervaluation.

Bear says

  • ↓Adjusted EBITDA declined 17.8% YoY, undershooting internal targets.
  • ↓Operating cash flow was negative $297M versus +$120M prior year.
  • ↓Leverage remains elevated at ~6.5×, posing risk amid rising rates.
  • ↓Soft patient volumes and negative growth trends pressure revenue.
  • ↓Medicaid reimbursement uncertainty threatens net revenue stability.
  • ↓Rising self-pay volumes heighten uncompensated care and credit risk.

Investment themes with CYH

Health Care Providers↓ -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 04-23-2026neutral

Transcript signals

Bull points

  • Earlier this week, we announced some significant investments in ambulatory surgery centers in our core markets, including the pending acquisition of a majority ownership interest in the Surgical Institute of Alabama, our largest acquisition since 2016. The surgery center performs more than 8,000 cases annually and is the largest multi-specialty surgery center in Alabama. We expect to close this transaction during the second quarter.
  • Same-store net revenue increased 3.1% year-over-year, driven by 3.7% growth in net revenue per adjusted admission, partly offset by a 0.5% decline in same-store adjusted admissions.
  • we expect as many as 80% of CHS's hospitals to receive a leapfrog A or B grade, up significantly from just 48% this time a year ago.

Bear points

  • adjusted EBITDA was on the low end of our internal expectations, declining 17.8% from the prior year period, reflecting our strategic transactions to reduce our debt, macroeconomic disruptions across the country, as well as the investments CHS is making in our future.
  • The quarter's results include an approximate $50 million year-over-year EBITDA drag from recently completed divestitures that went from being positive contributors in the prior year period to negative in the first quarter of 2026.
  • volumes and impairments were below expectations, including noteworthy softness in the left of procedures such as hips and knees, which along with negative contribution from recently divested operations led to margin compression.
Read full transcript analysis ›